MetaCap

Telomir Pharmaceuticals Statistics

NASDAQ: TELOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.364-0.0758 (-17.24%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Telomir Pharmaceuticals by the numbers

Telomir Pharmaceuticals has a market capitalization of $26.8 million based on 73.68M shares outstanding. With trailing EPS of $-0.96, Telomir Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 62.2% below its 50-day average and 69.0% below its 200-day average.

Average daily trading volume is 126.14K shares, or about $45,916 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

TELO valuation vs. peer median

TELO compared with the median of 8 peer companies
MetricTELOPeer medianDifference
Market cap$26.82M$28.67M-6%
Avg. volume126.14K207.85K-39%

Peer median across 8 companies: NSRX, BCTX, EDSA, PMN, AYTU, ATHE, RNTX, NNVC.

Valuation

Price and trading

Previous close
0.4398
Open
0.43
Day range
0.3578 – 0.4371
52-week range
0.353 – 1.58
52-week change
-71.56%
Beta
—
Volume
255.91K

Dividends and events

Annual dividend
None
Next earnings date
Aug 11, 2025

Additional statistics

Market Cap
26.82M
Forward Pe
-1.30
Eps
-0.96
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
1.58
Week52 Low
0.35
Avg Volume
126.14K
Shares Outstanding
73.68M
Ma50
0.96
Ma200
1.17
Earnings Date
Aug 11, 2025
Pct From52w High
-76.96%
Pct From52w Low
3.12%

Related